MSMS products


Request more information

Due to advancements in treatments of lysosomal storage disorders  and the subsequently increasing demand for newborn screening of these disorders, we are proud to release the NeoLSD™ MSMS Kit, the first commercial mass spectrometry based IVD kit for newborn screening of up to six lysosomal storage disorders from a single blood spot punch. The analysis of the enzymatic activity is intended as an aid in screening newborns for the following lysosomal storage disorders respectively; Gaucher Disease, Niemann-Pick A/B Disease, Pompe Disease, Krabbe Disease, Fabry Disease, and MPS I Disease.

The NeoLSD MSMS kit enables running up to 500 tests per instrument per day and easily switching between NeoBase™ 2 and NeoLSD™ kits on a single MSMS instrument. In addition, the NeoLSD™ kit provides you a wide analytical range, leading to potentially lower false positive rates, less costs associated with repeat enzyme activity tests and unnecessary molecular confirmatory testing. 

Product number: 3093-0010

Benefits of the assay

Screen for up to six LSDs from a single DBS punch and single incubation You can screen for the most commonly occured LSDs from a single DBS punch, saving time, human resources, and consumables
Wide dynamic range MSMS provides you a wide dynamic range, enabling better separation of affected and non-affected individuals, leading to less false positives less costs and subsequent parent anxiety
High sample sample volume per day With a run time of two minutes per sample, you can achieve a throughput that meets the demand of newborn screening
Products may not be licensed in accordance with their laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Kit includes everything for effective newborn screening of Lysosomal storage disorders